You are here: Home » News-CM » Companies » News
Business Standard

Natco Pharma receives ANDA approval for Generic Armodafinil Tablets

Capital Market 

From USFDA

has received final approval for Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the United Food and Drug Administration for generic version of Armodafinil Tablets, 50 mg, 150 mg and 250 mg. The Company and its marketing partner Breckenridge Pharmaceutical, Inc. plant to launch this product in USA market immediately.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Natco Pharma receives ANDA approval for Generic Armodafinil Tablets

From USFDA

From USFDA

has received final approval for Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the United Food and Drug Administration for generic version of Armodafinil Tablets, 50 mg, 150 mg and 250 mg. The Company and its marketing partner Breckenridge Pharmaceutical, Inc. plant to launch this product in USA market immediately.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Natco Pharma receives ANDA approval for Generic Armodafinil Tablets

From USFDA

has received final approval for Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the United Food and Drug Administration for generic version of Armodafinil Tablets, 50 mg, 150 mg and 250 mg. The Company and its marketing partner Breckenridge Pharmaceutical, Inc. plant to launch this product in USA market immediately.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22